Health Care
Johnson & Johnson tumbles on rating downgrade, after opioid ruling
Johnson & Johnson (NYSE: JNJ) continued the slide Wednesday after suffering a big loss in the previous trading session as…
4 biotech stocks that are ideal takeover targets
Speculation plays a big role when investing in biotech stocks, hence making them highly volatile. It could be after years…
Lannett stock jumps more than 15% after topping Q4 earnings and revenue estimates
Generic drug manufacturer Lannett's (NYSE: LCI) stock surged more than 15% after it reported Q4 earnings results. The company's bottom…
Veeva Systems Q2 profit beats estimates, CFO Tim Cabral to retire
Veeva Systems Inc. (NYSE: VEEV) reported a 58% jump in earnings for the second quarter of 2020 as higher subscription…
Why Arbutus Biopharma stock dipped to 11-year low?
Arbutus Biopharma Corporation (NASDAQ: ABUS) stock plunged to an 11-year low of $1.31 on Monday due to considerable downside risk…
Amgen to take over Celgene’s OTEZLA for $13.4 billion; Bristol-Myers Squibb increases share buyback plan
Bristol-Myers-Squibb (NASDAQ: BMY) announced that Amgen (NASDAQ: AMGN) will acquire Celgene's (NASDAQ: CELG) Otezla business for $13.4 billion in a…
Earnings preview: Veeva Systems likely to continue the momentum in Q2
Veeva Systems Inc. (NYSE: VEEV) is set to release its second-quarter earnings on Tuesday, August 27 after the market closes.…
Vertex Pharmaceuticals Q2 profit jumps 29%, beats estimates
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported a 29% jump in earnings for the second quarter of 2019 helped by strong…